1 Cannabis Stock I Would Buy, and One I Would Avoid The cannabis industry is rapidly growing, but will Canadian players be able to keep up? Barchart · Oct 18, 2024
2 Growth Stocks With 32% to 77% Upside in 2024 While AI stocks are the center of attention right now, many other growth stocks in various industries are going unnoticed. These stocks may benefit investors in the long run. Barchart · Mar 20, 2024
Tilray To Guide Patients On Their Medical Cannabis Journey, Launches New Products & 'CannaPoints' Program Tilray Brands, Inc.’s (Nasdaq: TLRY) (TSX:TLRY) Tilray Medical, has released new medical cannabis products, under Tilray and Aphria brands and launched CannaPoints, a new program designed to support pa Benzinga · Aug 25, 2022
EXCLUSIVE: Tilray CEO Shares Insider Insights Into Earnings, International Opportunities, Alcohol Market & More Tilray Brands Inc.'s (NASDAQ: TLRY) CEO Irwin Simon said on Thursday's "Cannabis Insider" that "Europe will legalize [cannabis] before the U.S." Benzinga · Jul 29, 2022
Tilray's Medical Cannabis Brand Aphria Launches Sleep-Oriented CBN Night Oil For Patients In Canada Tilray Brands, Inc.'s (NASDAQ: TLRY) (TSX:TLRY) medical cannabis brand, Aphria, has launched CBN Night Oil, the brand’s first CBN oil medical product formulated for patients’ nighttime use. Benzinga · Jun 7, 2022
Tilray Q3 Revenue Grows 23% YoY To $152M, Gives Update On Targeted Cost Synergies From Aphria Deal Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) reported financial results for the third fiscal quarter ended Feb. 28, 2022 with net revenue up 23% from the same quarter last year reaching $152 million. Benzinga · Apr 6, 2022